187 related articles for article (PubMed ID: 32858141)
1. Topical Application of Loperamide/Oxymorphindole, Mu and Delta Opioid Receptor Agonists, Reduces Sensitization of C-fiber Nociceptors that Possess Na
Uhelski ML; Bruce D; Speltz R; Wilcox GL; Simone DA
Neuroscience; 2020 Oct; 446():102-112. PubMed ID: 32858141
[TBL] [Abstract][Full Text] [Related]
2. Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.
Bruce DJ; Peterson CD; Kitto KF; Akgün E; Lazzaroni S; Portoghese PS; Fairbanks CA; Wilcox GL
Anesthesiology; 2019 Sep; 131(3):649-663. PubMed ID: 31343460
[TBL] [Abstract][Full Text] [Related]
3. In vivo optogenetic activation of Na
Uhelski ML; Bruce DJ; Séguéla P; Wilcox GL; Simone DA
J Neurophysiol; 2017 Jun; 117(6):2218-2223. PubMed ID: 28298301
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund's Adjuvant Models of Pain.
Matson DJ; Hamamoto DT; Bregman H; Cooke M; DiMauro EF; Huang L; Johnson D; Li X; McDermott J; Morgan C; Wilenkin B; Malmberg AB; McDonough SI; Simone DA
PLoS One; 2015; 10(9):e0138140. PubMed ID: 26379236
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
6. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
7. Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.
Gaveriaux-Ruff C; Nozaki C; Nadal X; Hever XC; Weibel R; Matifas A; Reiss D; Filliol D; Nassar MA; Wood JN; Maldonado R; Kieffer BL
Pain; 2011 Jun; 152(6):1238-1248. PubMed ID: 21295407
[TBL] [Abstract][Full Text] [Related]
8. Mu and delta opioid receptors on nociceptors attenuate mechanical hyperalgesia in rat.
Joseph EK; Levine JD
Neuroscience; 2010 Nov; 171(1):344-50. PubMed ID: 20736053
[TBL] [Abstract][Full Text] [Related]
9. Loperamide inhibits sodium channels to alleviate inflammatory hyperalgesia.
Wu Y; Zou B; Liang L; Li M; Tao YX; Yu H; Wang X; Li M
Neuropharmacology; 2017 May; 117():282-291. PubMed ID: 28216001
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl decreases discharges of C and A nociceptors to suprathreshold mechanical stimulation in chronic inflammation.
Moshourab R; Stein C
J Neurophysiol; 2012 Nov; 108(10):2827-36. PubMed ID: 22956796
[TBL] [Abstract][Full Text] [Related]
11. The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain.
Uhelski ML; Cain DM; Harding-Rose C; Simone DA
Neuroscience; 2013 Sep; 247():84-94. PubMed ID: 23673278
[TBL] [Abstract][Full Text] [Related]
12. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
[TBL] [Abstract][Full Text] [Related]
13. Primary afferent neurons express functional delta opioid receptors in inflamed skin.
Brederson JD; Honda CN
Brain Res; 2015 Jul; 1614():105-11. PubMed ID: 25911583
[TBL] [Abstract][Full Text] [Related]
14. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
15. Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.
Gendron L; Pintar JE; Chavkin C
Neuroscience; 2007 Dec; 150(4):807-17. PubMed ID: 17997230
[TBL] [Abstract][Full Text] [Related]
16. Effects of inflammation on the properties of Nav1.8-ChR2-positive and Nav1.8-ChR2-negative afferent mechanoreceptors in the hindpaw glabrous skin of mice.
Yamada A; Yamada A; Ling J; Furue H; Gu JG
Mol Pain; 2024; 20():17448069241240452. PubMed ID: 38438192
[TBL] [Abstract][Full Text] [Related]
17. Mu-opioid receptors in nociceptive afferents produce a sustained suppression of hyperalgesia in chronic pain.
Severino A; Chen W; Hakimian JK; Kieffer BL; Gaveriaux-Ruff C; Walwyn W; Marvizón JCG
Pain; 2018 Aug; 159(8):1607-1620. PubMed ID: 29677019
[TBL] [Abstract][Full Text] [Related]
18. Local loperamide injection reduces mechanosensitivity of rat cutaneous, nociceptive C-fibers.
Ringkamp M; Tal M; Hartke TV; Wooten M; McKelvy A; Turnquist BP; Guan Y; Meyer RA; Raja SN
PLoS One; 2012; 7(7):e42105. PubMed ID: 22848720
[TBL] [Abstract][Full Text] [Related]
19. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats.
He SQ; Yang F; Perez FM; Xu Q; Shechter R; Cheong YK; Carteret AF; Dong X; Sweitzer SM; Raja SN; Guan Y
Pain; 2013 Nov; 154(11):2477-2486. PubMed ID: 23880055
[TBL] [Abstract][Full Text] [Related]
20. Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity.
Griffith JI; Kim M; Bruce DJ; Peterson CD; Kitto KF; Mohammad AS; Rathi S; Fairbanks CA; Wilcox GL; Elmquist WF
J Pharmacol Exp Ther; 2022 Jan; 380(1):34-46. PubMed ID: 34663676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
